Does an Allergy to Fish Pre-empt an Adverse Protamine Reaction? A Case Report and a Literature Review
We report on the outcome for our patient and also discuss other risk factors and the types of reactions that can result when an adverse reaction to protamine occurs.
Successful Intraoperative Reversal of Heparin With Factor VII in a Patient With Protamine Reaction
We report the case of a patient who developed intractable bleeding after a severe protamine reaction following emergency repair of type A aortic dissection and was successfully treated with factor VII.
Methylene Blue to Treat Vasoplegia Due to a Severe Protamine Reaction: A Case Report
A review of the pathophysiologic characteristics associated with vasoplegia and the pharmacodynamics of methylene blue will potentially enable anesthesia providers to utilize this lifesaving drug when needed.
The End Organ Protection in Cardiac Surgery
Mortality and morbidity post cardiac surgery with cardiopulmonary bypass (CPB) remain relative stable over the last decades, while the number of patients with increased co-morbidity and more complex cardiac disease increases.
Methylene Blue and Vasoplegia: Who, When, and How
Vasoplegia has been observed in all age groups and in various clinical settings, such as anaphylaxis (including protamine reaction), sepsis, hemorrhagic shock, hemodialysis, and cardiac surgery.
From Extracorporeal Membrane Oxygenation to Ventricular Assist Device Oxygenation without Sternotomy
We report a method of minimally invasive LV drainage while the patient is receiving peripheral ECMO support and subsequent staged switch to paracorporeal LVAD without the need for a median sternotomy.
Early Risk of Mortality after Coronary Artery Revascularization in Patients with Left Ventricular Dysfunction and Potential Role of the Wearable Cardioverter Defibrillator
Implantable cardioverter defibrillator (ICD) implantation for prevention of sudden cardiac death is typically deferred for 90 days after coronary revascularization, but mortality may be highest early after cardiac procedures in patients with ventricular dysfunction. We determined mortality risk in post-revascularization patients with left ventricular ejection fraction (LVEF) ≤35% and compared survival to those discharged with a wearable cardioverter defibrillator (WCD).
Marfan Syndrome: Correct Diagnosis Can Save Lives
Marfan syndrome is a heritable disorder of the connective tissue that affects many systems of the body. However, the most serious complication in patients with Marfan syndrome is progressive enlargement of the aortic root, which may lead to aortic dissection, rupture, or aortic regurgitation.
Incompatible ABO-Plasma Exchange and its Impact on Patient Selection in Paediatric Cardiac Transplantation
We report the results of a decade of evolving plasma exchange experience and its impact upon patient selection.